Butterfly Network, Inc. (NYSE: BFLY) is a medical technology company that develops handheld, whole-body ultrasound devices powered by proprietary semiconductor technology. The company went public in February 2021 through a merger with GX Acquisition Corp. II, a blank-check company sponsored by GX Sponsor II LLC. Founded by serial entrepreneur Jonathan Rothberg, Butterfly Network operates in the medical devices and health technology sector, with its flagship iQ+ probe designed to bring point-of-care ultrasound imaging to clinicians and frontline providers globally. The company continues to trade on the New York Stock Exchange and filed its most recent Form 10-K with the SEC on February 27, 2026. For comprehensive data on BFLY's SPAC transaction history, filing timeline, and competitive positioning, create a free account at SpacDesk.